Nature Genetics :全球大规模癌症基因组数据公布

2012-06-05 卢秀玲 生物通

       为了促进癌症等疾病的研究,圣犹大儿童医院-华盛顿大学儿童癌症基因组计划公布了迄今为止最大的人类癌症基因组全面数据,这些数据将免费提供给全球的科学团队。所公布的信息数量是目前能从所有人类基因组资源中获取的高覆盖,全基因组数据的两倍之多,这些信息不仅能帮助癌症研究人员,而且对于其它疾病的研究人员来说,也十分有价值。其中一部分数据目前公布在5月29日

       为了促进癌症等疾病的研究,圣犹大儿童医院-华盛顿大学儿童癌症基因组计划公布了迄今为止最大的人类癌症基因组全面数据,这些数据将免费提供给全球的科学团队。所公布的信息数量是目前能从所有人类基因组资源中获取的高覆盖,全基因组数据的两倍之多,这些信息不仅能帮助癌症研究人员,而且对于其它疾病的研究人员来说,也十分有价值。其中一部分数据目前公布在5月29日的 Nature Genetics 杂志上。
儿童和成人癌症和白血病类型
儿童和成人癌症和白血病类型

       公布的520个基因组序列包含260个儿科癌症患者的肿瘤样品,以及相应对照的正常样品,儿童癌症基因组计划希望能到今年年底,完成1200个基因组序列的测定。

       每个样品都需要在30倍覆盖度水平上进行测序,以确保最大的精确度,圣犹大儿童医院的研究人员分析了这些基因组数据,找出每个儿童正常和癌变细胞中的差别,从而了解最致命儿童癌症中超过一半以上的致病原因,目前已有许多关键的成果发表在各大顶级杂志上。

       圣犹大儿童负责这一项目的科学主任:James Downing介绍说,“这方面的努力已经获得了比我们原来预期更多的发现”,“我们希望能将这些信息公开,让更多的科学团队看到,这样我们就能研发更多治疗这些儿童的新方法。并且在我们自己分析这些数据之前,就公开了信息,我们希望能其他研究人员能利用这些丰富的资源,探索儿童和成人其它许多类型的疾病。”

       儿童癌症基因组计划于2010年早期启动,是世界上最大的分析儿童癌症遗传起源的项目,在过去三年时间里,这一计划耗资约6500万美元,其中圣犹大儿童医院投资了大部分,5500万美元,包括2000万来自Kay Jewelers的资助。因此这也是第一个主要的私人赞助人类基因组测序项目即时分享了数据成果。目前此类开发数据大部分受到政府资助项目的限制,非政府资助项目一般也不公开。

      “这一先例是我们圣犹大儿童医院免费共享信息的一个承诺,在五十年前,我们就敞开了大门,自此免费共享信息已经成为了圣犹大儿童医院的标志”,圣犹大儿童医院懂事,及CEO:William Evans博士说,“儿童癌症基因组计划是一项独一无二的成果,这些信息能加速全球疾病研究的进程。”

       目前研究人员可以通过基于欧洲基因组-表型档案网站(Web-based European Genome-Phenome Archive),获取这些序列数据,具体地址为:www.ebi.ac.uk/ega/organisations/EGAO00000000046 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1877926, encodeId=ffed18e7926e8, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Sep 02 16:23:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066979, encodeId=122820669e957, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Oct 31 04:23:00 CST 2012, time=2012-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685860, encodeId=2de716858608a, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sat Jun 09 05:23:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879267, encodeId=b44418e926729, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Oct 18 08:23:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733599, encodeId=56961e33599f6, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Mon Jul 16 20:23:00 CST 2012, time=2012-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048440, encodeId=03002048440a8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Jun 06 08:23:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043276, encodeId=b5c020432e620, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Aug 20 22:23:00 CST 2012, time=2012-08-20, status=1, ipAttribution=)]
    2012-09-02 huperzia
  2. [GetPortalCommentsPageByObjectIdResponse(id=1877926, encodeId=ffed18e7926e8, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Sep 02 16:23:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066979, encodeId=122820669e957, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Oct 31 04:23:00 CST 2012, time=2012-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685860, encodeId=2de716858608a, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sat Jun 09 05:23:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879267, encodeId=b44418e926729, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Oct 18 08:23:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733599, encodeId=56961e33599f6, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Mon Jul 16 20:23:00 CST 2012, time=2012-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048440, encodeId=03002048440a8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Jun 06 08:23:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043276, encodeId=b5c020432e620, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Aug 20 22:23:00 CST 2012, time=2012-08-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1877926, encodeId=ffed18e7926e8, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Sep 02 16:23:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066979, encodeId=122820669e957, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Oct 31 04:23:00 CST 2012, time=2012-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685860, encodeId=2de716858608a, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sat Jun 09 05:23:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879267, encodeId=b44418e926729, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Oct 18 08:23:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733599, encodeId=56961e33599f6, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Mon Jul 16 20:23:00 CST 2012, time=2012-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048440, encodeId=03002048440a8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Jun 06 08:23:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043276, encodeId=b5c020432e620, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Aug 20 22:23:00 CST 2012, time=2012-08-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1877926, encodeId=ffed18e7926e8, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Sep 02 16:23:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066979, encodeId=122820669e957, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Oct 31 04:23:00 CST 2012, time=2012-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685860, encodeId=2de716858608a, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sat Jun 09 05:23:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879267, encodeId=b44418e926729, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Oct 18 08:23:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733599, encodeId=56961e33599f6, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Mon Jul 16 20:23:00 CST 2012, time=2012-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048440, encodeId=03002048440a8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Jun 06 08:23:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043276, encodeId=b5c020432e620, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Aug 20 22:23:00 CST 2012, time=2012-08-20, status=1, ipAttribution=)]
    2012-10-18 liye789132251
  5. [GetPortalCommentsPageByObjectIdResponse(id=1877926, encodeId=ffed18e7926e8, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Sep 02 16:23:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066979, encodeId=122820669e957, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Oct 31 04:23:00 CST 2012, time=2012-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685860, encodeId=2de716858608a, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sat Jun 09 05:23:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879267, encodeId=b44418e926729, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Oct 18 08:23:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733599, encodeId=56961e33599f6, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Mon Jul 16 20:23:00 CST 2012, time=2012-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048440, encodeId=03002048440a8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Jun 06 08:23:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043276, encodeId=b5c020432e620, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Aug 20 22:23:00 CST 2012, time=2012-08-20, status=1, ipAttribution=)]
    2012-07-16 canlab
  6. [GetPortalCommentsPageByObjectIdResponse(id=1877926, encodeId=ffed18e7926e8, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Sep 02 16:23:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066979, encodeId=122820669e957, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Oct 31 04:23:00 CST 2012, time=2012-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685860, encodeId=2de716858608a, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sat Jun 09 05:23:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879267, encodeId=b44418e926729, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Oct 18 08:23:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733599, encodeId=56961e33599f6, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Mon Jul 16 20:23:00 CST 2012, time=2012-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048440, encodeId=03002048440a8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Jun 06 08:23:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043276, encodeId=b5c020432e620, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Aug 20 22:23:00 CST 2012, time=2012-08-20, status=1, ipAttribution=)]
    2012-06-06 cy0324
  7. [GetPortalCommentsPageByObjectIdResponse(id=1877926, encodeId=ffed18e7926e8, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Sun Sep 02 16:23:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066979, encodeId=122820669e957, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Oct 31 04:23:00 CST 2012, time=2012-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685860, encodeId=2de716858608a, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sat Jun 09 05:23:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879267, encodeId=b44418e926729, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Oct 18 08:23:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733599, encodeId=56961e33599f6, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Mon Jul 16 20:23:00 CST 2012, time=2012-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048440, encodeId=03002048440a8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Wed Jun 06 08:23:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043276, encodeId=b5c020432e620, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Aug 20 22:23:00 CST 2012, time=2012-08-20, status=1, ipAttribution=)]
    2012-08-20 ylz8403

相关资讯

Cell:21个乳腺癌癌症基因组分析详情

      来自著名Sanger研究院的研究人员在Cell杂志上接连发表两篇文章,通过测序分析21个乳腺癌基因组,发现了癌症发生发展过程中出现的突变,解析了癌症发生发展的全过程。         21个乳腺癌背后的奥秘        研究组在21个乳腺癌基因组中发现了将近20万个